Is Intraoperative Pathology Needed if 5-Aminolevulinic-Acid-Induced Tissue Fluorescence Is Found in Stereotactic Brain Tumor Biopsy?
暂无分享,去创建一个
J. Furtner | E. Knosp | B. Kiesel | S. Wolfsberger | G. Widhalm | A. Wöhrer | T. Roetzer | M. Millesi | P. Mercea | M. Bissolo
[1] M. Preusser,et al. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients. , 2018, Neurosurgical focus.
[2] Neda Haj-Hosseini,et al. 405 nm versus 633 nm for protoporphyrin IX excitation in fluorescence‐guided stereotactic biopsy of brain tumors , 2016, Journal of biophotonics.
[3] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[4] A. Matsumura,et al. Photodynamic Diagnosis Using 5‐Aminolevulinic Acid in 41 Biopsies for Primary Central Nervous System Lymphoma , 2015, Photochemistry and photobiology.
[5] Alexandra J Golby,et al. Comparative effectiveness of frame-based, frameless, and intraoperative magnetic resonance imaging-guided brain biopsy techniques. , 2015, World neurosurgery.
[6] S. Bojanić,et al. Yield and complications of frame-based and frameless stereotactic brain biopsy – The value of intra-operative histological analysis , 2014, British journal of neurosurgery.
[7] Daniela Prayer,et al. 5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement , 2013, PloS one.
[8] H. Kishima,et al. 11C‐methionine uptake and intraoperative 5‐aminolevulinic acid‐induced fluorescence as separate index markers of cell density in glioma , 2012, Cancer.
[9] Boguslaw Tomanek,et al. Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies , 2012, Neurosurgical Review.
[10] M. Hefti,et al. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies , 2012, Acta Neurochirurgica.
[11] Kimito Yamada,et al. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. , 2011, Journal of neurosurgery.
[12] Thomas Czech,et al. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[13] A. Belli,et al. Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. , 2010, Journal of neurosurgery.
[14] Johan M. Kros,et al. Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre , 2010, Acta Neurochirurgica.
[15] D. Prayer,et al. 5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement , 2010, Cancer.
[16] Jacques J. Morcos,et al. Outcomes and Management Strategies after Nondiagnostic Stereotactic Biopsies of Brain Lesions , 2009, Stereotactic and Functional Neurosurgery.
[17] C. Avezaat,et al. Safety and efficacy of frameless and frame-based intracranial biopsy techniques , 2008, Acta Neurochirurgica.
[18] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[19] A. Teramoto,et al. Photodiagnosis for frameless stereotactic biopsy of brain tumor. , 2007, Photodiagnosis and photodynamic therapy.
[20] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[21] M. Mittler,et al. Stereotactic brain biopsies and operative complications: technique to further decrease risks , 2005, Acta Neurochirurgica.
[22] R. Grossman,et al. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies , 2005, Acta Neurochirurgica.
[23] N. Dorward,et al. Clinical Validation of True Frameless Stereotactic Biopsy: Analysis of the First 125 Consecutive Cases , 2001, Neurosurgery.
[24] W. Hall. The safety and efficacy of stereotactic biopsy for intracranial lesions , 1998, Cancer.